Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Le Guen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Revue Des Maladies Respiratoires|December 31, 2021
[Pulmonary manifestations induced by osimertinib]Y Le Guen, M Lederlin, L Triquet, et al.
Revue Des Maladies Respiratoires|September 8, 2001
[Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer]B Lebeau, T Urban, M Baud, et al.
Revue Des Maladies Respiratoires|April 16, 2025
[Durable Benefit from Immunotherapy in Advanced NSCLC: The BREATH Cohort]S Deslais, C Pierre, T Goter, et al.
Journal De Radiologie, D'Electrologie, Et De Medecine Nucleaire|June 1, 1971
[Information treatment with radioisotope scanning and radioisotope scanning with motion camera]J Y Herry, J C Houy, J Guelfi, et al.
Scientific Reports|March 3, 2023
Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancerCharles Ricordel, L Chaillot, E I Vlachavas, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Revue Des Maladies Respiratoires|December 31, 2021
[Pulmonary manifestations induced by osimertinib]Y Le Guen, M Lederlin, L Triquet, et al.
Revue Des Maladies Respiratoires|September 8, 2001
[Chemoradiotherapy-chemotherapy for grade III inoperable non-small-cell lung cancer]B Lebeau, T Urban, M Baud, et al.
Revue Des Maladies Respiratoires|April 16, 2025
[Durable Benefit from Immunotherapy in Advanced NSCLC: The BREATH Cohort]S Deslais, C Pierre, T Goter, et al.
Journal De Radiologie, D'Electrologie, Et De Medecine Nucleaire|June 1, 1971
[Information treatment with radioisotope scanning and radioisotope scanning with motion camera]J Y Herry, J C Houy, J Guelfi, et al.
Scientific Reports|March 3, 2023
Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancerCharles Ricordel, L Chaillot, E I Vlachavas, et al.
Pageof 2